Siemens New Urine Chemistry Analyzer Receives CE Mark
02 May 2012

Siemens Healthcare Diagnostics has announced that it has received CE Mark approval to sell its CLINITEK Novus™ Automated Urine Chemistry Analyzer. The analyzer is the latest in the company’s portfolio for central laboratories in Europe.

Urinalysis plays a key role in the central lab setting as a non-invasive and cost effective way to detect early kidney disease, urinary tract infections, diabetes and liver dysfunction. Laboratories need the ability to manage high volumes of samples, while delivering consistent and reliable results.

The CLINITEK Novus analyzer, which is also available in other non-European countries, combines proven dry-pad urine chemistry technology with an easy-to-use cassette test format. With a throughput of up to 240 samples per hour, the analyzer streamlines workflow, simplifies routine analysis and STAT testing, and delivers consistent, high-quality results. A digital imaging measurement system is utilized to improve accuracy of results, and new ergonomic features such as the tiltable, color-touch screen and intuitive user interface, customized menu options, simplified, cassette-based test handling and automatic entry of cassette lot number and expiration date enhance ease-of-use.

“In working and listening to our customers, we know that they want instruments that are easy to use, offer high throughput and plenty of walk-away time capability,” said David Stein, PhD, CEO, Point of Care Business Unit, Siemens Healthcare Diagnostics. “When developing the CLINITEK Novus analyzer, we incorporated features that build upon Siemens proven track record in urinalysis and directly address the needs of our customers to enhance productivity and efficiency.”

For more information about the CLINITEK Novus analyzer, please follow the company website link below.

Request Info


Company website

Siemens Healthcare Diagnostics
profile photo

Sonia Nicholas
Clinical Diagnostics Editor